SYN - Synthetic Biologics Inc.'s (SYN) CEO Steven Shallcross on Q3 2021 Results - Earnings Call Transcript

Synthetic Biologics, Inc. (SYN) Q3 2021 Earnings Conference Call November 03, 2021, 04:30 PM ET Company Participants Vincent Perrone - Director, Corporate Communications Steven Shallcross - Chief Executive and Financial Officer Michael Kaleko - Senior Vice President-Research and Development Vince Wacher - Head of Corporate and Product Development Conference Call Participants James Molloy - Alliance Global Partners Michael Okunewitch - Maxim Group Presentation Operator Good afternoon, and welcome to Synthetic Biologics’ 2021 Third Quarter Investor Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded. At this time, I would like to turn the call over to Vincent Perrone, Director of Corporate Communication at Synthetic Biologics. Vincent? Vincent Perrone Thank you, Simona and good afternoon, everyone. Welcome to Synthetic Biologics 2021 third quarter investor conference call. Today, I'm joined

For further details see:

Synthetic Biologics, Inc.'s (SYN) CEO Steven Shallcross on Q3 2021 Results - Earnings Call Transcript